Anti Allergy by Richmond Pharmaceuticals, Inc.
Dosage form: tablet
Ingredients: CHLORPHENIRAMINE MALEATE 4mg
Labeler: Richmond Pharmaceuticals, Inc.
NDC Code: 54738-103
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
(in each tablet)
Chlorpheniramine Maleate 4 mg
temporarily relieves these symptoms of hay fever or other upper respiratory allergies :
- runny nose
- itchy nose or throat
- itchy, watery eyes
Ask a doctor before use if you have
- trouble urinating due to an enlarged prostate gland
- a breathing problem such as emphysema or chronic bronchitis
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers
When using this product
- you may get drowsy
- avoid alcoholic drinks
- alcohol, sedatives & tranquilizers may increase drowsiness
- be careful when driving a motor vehicle or operating a machine
- excitability may occur, especially in children
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
|Adults & children 12 years and over||take 1 tablet every 4 to 6 hours, not more than 6 tablets in 24 hours|
|children 6 years to under 12 years||take ½ tablet every 4 to 6 hours not more than 3 tablets in 24 hours|
|children under 6 years||do not use|
- each tablet contains: calcium 40 mg
- store between 15°-30°C (59°-86°F)
- protect from moisture
croscarmellose sodium, D&C yellow #10 (al-lake), dicalcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide, starch
call 804-270-4498, 8.30 am-4.30 pm ET, Monday - Friday
TAMPER EVIDENT: DO NOT USE IF CARTON IS OPENED OR BLISTER UNIT IS BROKEN OR DAMAGED
chlorpheniramine maleate tablet
|Labeler - Richmond Pharmaceuticals, Inc. (043569607)|
|Registrant - Advance Pharmaceutical Inc. (078301063)|
|Advance Pharmaceutical Inc.||078301063||manufacture(54738-103)|
Medically reviewed on Oct 30, 2017